USPTFS: Hepatitis B screening

Article

Published in JAMA Network, a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

Dr. Bobby LazzaraPublished in JAMA Network a Reaffirmation from the US Preventive Services Task Force on screening for Hepatitis B virus infection in pregnant women.

The US Preventative Services Task Force commissioned a reaffirmation evidence update looking at any new evidence solid enough to institute a change in any prior recommendations.

Findings of the review indicated that serologic testing identifies the infection, and Current Interventions are effective for preventing perinatal transmission.

As a result the US Preventative Services Task Force reaffirmed its position that screening for hepatitis B virus provides substantial benefit in pregnant women and should be accomplished at their first prenatal visit.

Related Videos
Learning what women prefer in STI preventive care
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
USPSTF releases new recommendations for breast cancer screening | Image Credit: uclahealth.org
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
© 2024 MJH Life Sciences

All rights reserved.